MS-N126 · Supportive care · Human evidence · Appraised 24 October 2026

Can elastic kinesiology tape reduce established breast-cancer-related arm lymphedema?

Evidence at a glance

• Evidence label: Uncertain benefit; should not replace compression
• Benefit: Some small trials report changes in swelling or function, but findings are inconsistent and study quality is limited.
• Certainty: Low certainty because taping methods, comparators and background decongestive therapy vary, and several studies are small.
• Risk: Skin irritation, blistering or tearing can matter after radiotherapy or surgery.

What was studied

Population and design: Trials largely involve women with established breast-cancer-related arm lymphedema; one five-group randomized study enrolled 150 participants.

Studied regimen: Tape applications differ in direction, tension and duration. In the 150-person study, participants also received elements of intensive complex physiotherapy, including education and exercise; groups differed in bandaging or taping strategy.

What the evidence found

The 150-person trial found improvements within several groups but did not establish tape as a consistent replacement for multilayer compression. A 2023 review identified seven randomized trials and judged the evidence low quality; a 2024 meta-analysis suggested possible volume reduction but emphasized heterogeneity and limited certainty.

How to interpret it

Because tape is frequently added to active rehabilitation, within-group improvement cannot be credited to tape alone. Small samples, inconsistent measurement and short follow-up make the magnitude and durability uncertain. There is no cancer-control evidence.

Practical safety context

Do not tape over open, infected, actively irradiated or very fragile skin. Stop for itching, blistering, pain, color change or worsening swelling. Sudden swelling, redness, fever, chest pain or breathlessness needs medical assessment, not taping. Product adhesives differ, so trial results do not transfer automatically to every tape.

Questions for the care team

• Is the symptom or complication being caused by something that needs conventional treatment first?
• Would blood counts, anticoagulants, infection risk, surgery, radiation effects or implanted devices change whether this is safe?
• What outcome will we track, and when should we stop if it is not helping?

Funding and conflicts

Funding and conflicts were inconsistently reported across the included trials and reviews.

Sources

• Five-group randomized trial (PMID 32580577)
• 2023 systematic review (PMID 36847633)
• 2024 meta-analysis (PMID 38834497)
• Earlier controlled trial (PMID 24377096)

Last literature search: 24 October 2026. Record appraisal: 24 October 2026. This page is educational and does not replace individualized medical advice. Symptom improvement must not be interpreted as evidence of tumor response, delayed recurrence or longer survival.